Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Entacapone,Levodopa and Carbidopa Tablets（Ⅳ）

Approval Number

国药准字HJ20181219

CompanyORION CORPORATION

Registration Date

June 13, 2022

Previous Approval Numbers

H20181219

Drug Information

Generic Name

恩他卡朋双多巴片(Ⅳ)

Trade Name

达灵复

Dosage Form

片剂

Strength

左旋多巴200mg,卡比多巴50mg,恩他卡朋200mg

Drug Type

化学药品

Registration Date

June 13, 2022

Expiry Date

June 12, 2027

Company Information

Applicant Company

Company NameORION CORPORATION

Company Address

Orionintie 1, FIN-02200 Espoo,Finland

Manufacturing Company

Company NameORION CORPORATION

Company Address

Orionintie 1, FIN-02200 Espoo,Finland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

恩他卡朋双多巴片(Ⅳ) - NMPA 批准文号 | MedPath